$0.7417
-0.02-2.54%
At close: -
$0.7109
-0.03-4.16%
After Hours: Jan 24, 7:52 PM EDT
Comments
Loading...
Calidi Biotherapeutics (AMEX:CLDI) Stock, Earnings Estimates, EPS, And Revenue
Calidi Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$-0.650
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Calidi Biotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Calidi Biotherapeutics (CLDI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.65 | $-0.85 | 23.5 % |
| Q2 | 2024-08-13 | $-1.40 | $-2.20 | 36.4 % |
| Q1 | 2024-05-14 | $-2.00 | $-2.70 | 25.9 % |
| Q4 | 2024-03-15 | $-2.30 | $-2.00 | -15.0 % |
Calidi Biotherapeutics (CLDI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Calidi Biotherapeutics (AMEX:CLDI) reporting earnings?
Calidi Biotherapeutics (CLDI) is scheduled to report earnings on March 14, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Calidi Biotherapeutics (AMEX:CLDI)?
The Actual EPS was $-0.65, which beat the estimate of $-0.85.
What were Calidi Biotherapeutics’s (AMEX:CLDI) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.